Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PB2 is a subunit of the RNA-dependent RNA polymerase complex of influenza A virus. It is critical for transcription initiation by binding to the 5' cap structures of host pre-mRNAs, a process called "cap-snatching." PB2 also influences host adaptation, pathogenicity, and evasion of the innate immune response.
PB2 is a subunit of the RNA-dependent RNA polymerase, which is essential for viral transcription and replication. Inhibiting its cap-binding or polymerase activity would disrupt the viral lifecycle.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polymerase Basic Protein 2 Subunit (PB2).